57 results on '"Brito ML"'
Search Results
2. Genetic Signature of a Healthy Lifestyle: New Horizons for Preventing Noncommunicable Chronic Diseases by Modulating MicroRNA-155.
- Author
-
Coutinho-Wolino KS, Brito ML, Trigueira PC, de Menezes LO, do Nascimento CS, and Stockler-Pinto MB
- Abstract
The development and progression of several noncommunicable diseases (NCDs) are associated with microRNA (miR) 155 (miR-155) activation, which promotes inflammation and oxidative stress. In particular, miR-155 regulates nuclear transcription factor-kappa B (NF-κB) by silencing gene expression of proteins involved in NF-κB suppression, such as suppressor of cytokine signaling 1 (SOCS1) and SH-2 containing inositol 5' polyphosphate 1 (SHIP1), increases the production of reactive oxygen species, and suppresses gene expression of antioxidant enzymes through nuclear factor erythroid 2-related factor 2 (Nrf2) inhibition. In this context, a healthy lifestyle based on a diet rich in nutrients and bioactive compounds as well as regular physical activity may modulate the activity of several miRs. Following this concept, studies involving nutrients, bioactive compounds, and physical activity have been developed to modulate miR-155 activation. This narrative review aims to discuss how a healthy lifestyle based on a diet rich in nutrients, bioactive compounds, and physical activity may modulate the miR-155 pathway and consequently prevent the development and progression of NCDs. Nutrients and bioactive compounds from food may act by inhibiting pathways that promote miR-155 activation such as NF-κB and promote activation of pathways that are associated with the downregulation of miR-155, such as Nrf2, and SOCS1 pathways. Regular physical activity also seems to influence miR-155 levels through an improvement in the immune system during muscle recovery. There is relevant evidence that shows a positive effect of nutrients, bioactive compounds, and physical activity with the modulation of miR-155, which can potentially provide benefits in the clinical setting in cases of NCDs., (© The Author(s) 2024. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
3. Unstressing the Reticulum: Nutritional Strategies for Modulating Endoplasmic Reticulum Stress in Obesity.
- Author
-
Brito ML, Coutinho-Wolino KS, Almeida PP, Trigueira PC, Alves APP, Magliano DC, and Stockler-Pinto MB
- Subjects
- Humans, Animals, Endoplasmic Reticulum metabolism, Lipid Metabolism drug effects, Inflammation metabolism, Polyphenols pharmacology, Antioxidants pharmacology, Signal Transduction, Flavonoids pharmacology, Endoplasmic Reticulum Stress drug effects, Obesity metabolism, Obesity diet therapy, Oxidative Stress drug effects
- Abstract
The progression of obesity involves several molecular mechanisms that are closely associated with the pathophysiological response of the disease. Endoplasmic reticulum (ER) stress is one such factor. Lipotoxicity disrupts endoplasmic reticulum homeostasis in the context of obesity. Furthermore, it induces ER stress by activating several signaling pathways via inflammatory responses and oxidative stress. ER performs crucial functions in protein synthesis and lipid metabolism; thus, triggers such as lipotoxicity can promote the accumulation of misfolded proteins in the organelle. The accumulation of these proteins can lead to metabolic disorders and chronic inflammation, resulting in cell death. Thus, alternatives, such as flavonoids, amino acids, and polyphenols that are associated with antioxidant and anti-inflammatory responses have been proposed to attenuate this response by modulating ER stress via the administration of nutrients and bioactive compounds. Decreasing inflammation and oxidative stress can reduce the expression of several ER stress markers and improve clinical outcomes through the management of obesity, including the control of body weight, visceral fat, and lipid accumulation. This review explores the metabolic changes resulting from ER stress and discusses the role of nutritional interventions in modulating the ER stress pathway in obesity., (© 2024 Wiley‐VCH GmbH.)
- Published
- 2024
- Full Text
- View/download PDF
4. Brazil nut-enriched diet modulates bone mineral density and body composition in an experimental model of chronic kidney disease.
- Author
-
Da Cruz BO, Almeida PP, Silva-Costa N, Brito ML, Degani VAN, da Silva EM, Magliano DC, Mebarek S, Brizuela L, Cardozo LFMF, and Stockler-Pinto MB
- Subjects
- Animals, Male, Rats, Absorptiometry, Photon, Calcium blood, Nuts, Bone Density, Rats, Wistar, Body Composition, Renal Insufficiency, Chronic diet therapy, Renal Insufficiency, Chronic physiopathology, Disease Models, Animal, Diet methods, Bertholletia, Femur physiopathology
- Abstract
Objective: This study investigates the effects of a Brazil nut-enriched diet on body composition and bone parameters in CKD animal model., Methods: Male Wistar rats were assigned to the following groups: Sham (n=8), Nx (n=6), nephrectomized rats, and NxBN (n=6), nephrectomized rats and an enricheddiet with 5% Brazil nut. Body composition parameters were obtained by dual-energy X- ray absorptiometry (DXA). Bioclin kits determined plasmatic calcium. The femurs werecollected to determine absolute mass and length, bone mineral density, and biomechanical tests., Results: The NxBN group exhibited a higher total body bone mineral density (BMD) value than the Nx group (0.177±0.004g/cm
2 vs 0,169±0.003g/cm2 ; p=0.0397). No significant differences were observed regarding absolute mass, length, BMD, and biomechanical parameters in the femurs of the groups. Moreover, no significant differences were found in plasmatic calcium levels among the groups., Conclusions: Brazil-nut enriched diet modulated BMD in CKD experimental model, and further studies are demanded to understand the pathways involved in this finding., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
5. Brazil nuts potential: effects on lipid peroxidation and heart health in nephrectomized rats.
- Author
-
Menezes AC, Brito ML, Almeida PP, Da Cruz BO, da Silva Costa N, D'Avila Pereira A, Castañon C, Nunes Degani VA, Medeiros de França Cardozo LF, Magliano DC, and Stockler-Pinto MB
- Abstract
Objectives: To investigate the effects of a Brazil nut-enriched diet on the wall thickness and the left ventricular chamber diameter of the heart, and lipid peroxidation in a CKD-induced model., Methods: Male Wistar rats at 12 weeks of age were divided into two groups (n=16/group): the Nx group, which underwent 5/6 nephrectomy, and the Sham group, as a control. After 5 weeks, the groups were subdivided according to diet (n=8/group): the Nx and Sham groups received a control diet; the Nx5% and Sham5% groups received a diet enriched with 5 % Brazil nuts for 8 weeks. The left ventricular thickening and chamber diameter were determined. Plasma biochemical parameters were evaluated. Analysis of thiobarbituric acid reactive substances (TBARS) and antioxidant enzyme activity was performed in the plasma and the left ventricle (LV). LV mRNA expression of nuclear factor-kappa B (NF-κB) and nuclear factor erythroid 2-related factor 2 (Nrf2) was evaluated by reverse transcription-polymerase chain reaction., Results: The Nx5% group showed a remodeled LV wall with decreased thickness compared to the Nx group (p=0.016). Furthermore, LV TBARS concentration was reduced in the Nx5% group (p=0.0064). In addition, the Nx5% group showed an increase in plasma GPx activity (p=0.0431). No significant results were found concerning the LV mRNA expression of NF-κB and Nrf2 genes., Conclusions: A Brazil nut-enriched diet decreased LV thickness and LV TBARS concentration and increased GPx activity in a 5/6 nephrectomy experimental model, making it a promising adjuvant therapy to improve antioxidant status and cardiovascular outcomes in chronic kidney disease., (© 2024 Walter de Gruyter GmbH, Berlin/Boston.)
- Published
- 2024
- Full Text
- View/download PDF
6. Is the enteric nervous system a lost piece of the gut-kidney axis puzzle linked to chronic kidney disease?
- Author
-
Almeida PP, Brito ML, Thomasi B, Mafra D, Fouque D, Knauf C, Tavares-Gomes AL, and Stockler-Pinto MB
- Subjects
- Humans, Animals, Kidney physiopathology, Gastrointestinal Microbiome, Oxidative Stress, Dysbiosis complications, Gastrointestinal Tract physiopathology, Gastrointestinal Tract metabolism, Inflammation, Enteric Nervous System physiopathology, Renal Insufficiency, Chronic physiopathology, Renal Insufficiency, Chronic metabolism
- Abstract
The enteric nervous system (ENS) regulates numerous functional and immunological attributes of the gastrointestinal tract. Alterations in ENS cell function have been linked to intestinal outcomes in various metabolic, intestinal, and neurological disorders. Chronic kidney disease (CKD) is associated with a challenging intestinal environment due to gut dysbiosis, which further affects patient quality of life. Although the gut-related repercussions of CKD have been thoroughly investigated, the involvement of the ENS in this puzzle remains unclear. ENS cell dysfunction, such as glial reactivity and alterations in cholinergic signaling in the small intestine and colon, in CKD are associated with a wide range of intestinal pathways and responses in affected patients. This review discusses how the ENS is affected in CKD and how it is involved in gut-related outcomes, including intestinal permeability, inflammation, oxidative stress, and dysmotility., Competing Interests: Declaration of competing interest CK is the co-founder of Enterosys S.A.S. (Labège, France)., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer.
- Author
-
Bonadio RC, de Sousa IM, Balint FC, Comini ACM, Tavares MC, Madasi F, Bines J, Ferreira RDP, Rosa DD, Santos CL, de Souza ZS, Assad-Suzuki D, de Araújo JAP, Gagliato DM, Dos Anjos CH, Zucchetti BM, Ferrari A, de Brito ML, Cangussu R, Monteiro MMF, Hoff PM, Testa L, and Barroso-Sousa R
- Abstract
Neoadjuvant pembrolizumab plus chemotherapy (P + CT) has emerged as a standard of care for stage II-III triple-negative breast cancer (TNBC). However, the best anthracycline-cyclophosphamide (AC) schedule remains to be determined. While the KEYNOTE-522 regimen employs AC every 3 weeks (q3w AC), previous studies have shown overall survival benefits of dose-dense regimens for early-stage breast cancer. The Neo-Real study (GBECAM-0123) is a real-world data effort evaluating patients with TNBC treated with neoadjuvant P + CT in ten cancer centers since July 2020. The objective of this analysis was to evaluate the effectiveness and safety of dose-dense AC (ddAC) versus q3w AC. Among 333 patients included until November 2023, 311 completed neoadjuvant therapy and 279 underwent surgery with pathology reports available; ddAC was used in 58.2% and q3w AC in 41.8% of the cases. Most patients (69.1%) had stage II TNBC. A pCR was observed in 65.4% with ddAC and 58.7% with q3w AC (P = 0.260), while RCB 0-1 occurred in 82.4% and 73.5%, respectively (P = 0.115). Patients with stage III disease had a numerically higher pCR with ddAC (59% vs 40%, P = 0.155), while pCR rates were similar regardless of AC regimen in stage II disease (66.6% vs 64.5%; P = 0.760). While no significant disparities in drug discontinuation was noted, ddAC showed a trend towards higher rates of grade ≥3 AE (40.5% vs. 30.7%, P = 0.092). The Neo-Real study could not rule out a difference between ddAC and q3w AC during neoadjuvant P + CT. The observation of a potentially higher pCR with ddAC in stage III disease warrants further investigation., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
8. Effects of dietary compounds on nuclear factor erythroid 2-related factor 2 (Nrf2) modulation in chronic kidney disease: a systematic review of clinical trials.
- Author
-
de Castro Trigueira P, Coutinho-Wolino KS, Brito ML, de Oliveira Leal V, de França Cardozo LFM, Fouque D, Mafra D, and Barcza Stockler-Pinto M
- Abstract
Nuclear factor-erythroid 2-related factor 2 (Nrf2) is an important transcription factor that activates antioxidant genes and increases detoxifying enzymes. Studies have shown that dietary compounds can activate the Nrf2 expression and improve the antioxidant response in patients with exacerbated oxidative stress, such as chronic kidney disease (CKD). We aimed to evaluate the efficacy of nutritional interventions on Nrf2 expression and phase II antioxidant enzymes in clinical trials in CKD. We searched PubMed, Lilacs, Embase, Scopus, and Cochrane Library databases of published clinical trials and the Cochrane tool was used for the quality assessment of the studies included. We reported this review according to the PRISMA and it was registered in PROSPERO (42023389619). Thirty-nine studies were included in this review; nine evaluated the Nrf2 expression and three showed an increase in its expression. Twenty-three studies found an increase in the antioxidant enzyme levels, including superoxide dismutase, catalase, and glutathione peroxidase. Moreover, a high risk of bias was found in most of the studies and high heterogeneity in the designs, type, and duration of supplementation administered. These results suggest that dietary supplementations have a promising effect on the antioxidant enzyme response, however, it is recommended that further studies should be carried out.
- Published
- 2024
- Full Text
- View/download PDF
9. Stealth and Biocompatible Gold Nanoparticles through Surface Coating with a Zwitterionic Derivative of Glutathione.
- Author
-
Guido VS, Olivieri PH Jr, Brito ML, Prezoto BC, Martinez DST, Oliva MLV, and Sousa AA
- Subjects
- Humans, Particle Size, Adsorption, Coated Materials, Biocompatible chemistry, Coated Materials, Biocompatible pharmacology, Gold chemistry, Metal Nanoparticles chemistry, Glutathione chemistry, Surface Properties
- Abstract
Gold nanoparticles (AuNPs) hold promise in biomedicine, but challenges like aggregation, protein corona formation, and insufficient biocompatibility must be thoroughly addressed before advancing their clinical applications. Designing AuNPs with specific protein corona compositions is challenging, and strategies for corona elimination, such as coating with polyethylene glycol (PEG), have limitations. In this study, we introduce a commercially available zwitterionic derivative of glutathione, glutathione monoethyl ester (GSH
zwt ), for the surface coating of colloidal AuNPs. Particles coated with GSHzwt were investigated alongside four other AuNPs coated with various ligands, including citrate ions, tiopronin, glutathione, cysteine, and PEG. We then undertook a head-to-head comparison of these AuNPs to assess their behavior in biological fluid. GSHzwt -coated AuNPs exhibited exceptional resistance to aggregation and protein adsorption. The particles could also be readily functionalized with biotin and interact with streptavidin receptors in human plasma. Additionally, they exhibited significant blood compatibility and noncytotoxicity. In conclusion, GSHzwt provides a practical and easy method for the surface passivation of AuNPs, creating "stealth" particles for potential clinical applications.- Published
- 2024
- Full Text
- View/download PDF
10. Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study.
- Author
-
Suzuki DA, Morelle AM, de Brito ML, Paes FR, Mattar A, Leal JHS, Simon SD, Lima EMA, Werutsky G, Piotto GHM, Bines J, Damiani LP, Macedo A, Campos L, and Buehler AM
- Subjects
- Female, Humans, Aminopyridines adverse effects, Middle Aged, Aromatase Inhibitors adverse effects, Breast Neoplasms drug therapy, Breast Neoplasms pathology, Purines
- Abstract
Purpose: Cyclin inhibitors plus endocrine therapy represent the reference standard for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) locally advanced or metastatic breast cancer (ABC). Efficacy results on hard end points such as overall survival come from well-designed randomized clinical trials (RCTs). However, a limitation of RCTs is the low external results validity, and their extrapolation to a broader population may not be appropriate. Real-world studies can overcome these limitations, also increasing the reliability of RCTs., Materials and Methods: The BrasiLEEira was an observational, longitudinal, retrospective, multicenter study to evaluate the effectiveness and safety of ribociclib plus nonsteroidal aromatase inhibitors in Brazilian women age 18 years or older with HR+/HER2- ABC. The study was approved by the institutional review boards of all 11 hospitals. Data were collected anonymously from medical records using an electronic case report form designed by an independent academic research organization, which conducted the study considering all recommendations of international guidelines. The primary end point was 1-year progression-free survival (PFS) rate. Secondary end points included mortality, dose reduction, and safety., Results: The mean age of 76 patients was 57 years, and 28.9% were Black/Brown. The most prevalent comorbidity was arterial hypertension (34.7%). About 26.0% had endocrine-resistant disease, and 54.1% had more than three metastatic sites. The PFS rate was 77.6%. Three patients died (3.9%). Dose reductions occurred in 37.7% of patients. The most common adverse event was neutropenia (68.4%)., Conclusion: The high-quality evidence from the BrasiLEEira study corroborates the RCTs' findings, expanding its validity to a broader spectrum and underrepresented population who may benefit from ribociclib treatment.
- Published
- 2024
- Full Text
- View/download PDF
11. Brazil Nut-Enriched Diet Modulates Enteric Glial Cells and Gut Microbiota in an Experimental Model of Chronic Kidney Disease.
- Author
-
Almeida PP, Da Cruz BO, Thomasi B, Menezes ÁC, Brito ML, Costa NDS, Ito RVA, Degani VAN, Daleprane JB, Magliano DC, Tavares-Gomes AL, and Stockler-Pinto MB
- Subjects
- Rats, Animals, Diet, Neuroglia metabolism, Bertholletia, Gastrointestinal Microbiome, Renal Insufficiency, Chronic metabolism
- Abstract
Introduction: Chronic kidney disease (CKD) promotes gut dysbiosis, and enteric glial reactivity, a feature of intestinal inflammation. Brazil nut modulated enteric glial profile in healthy animals and could modulate these cells in 5/6 nephrectomized rats. Methods: A 5/6 nephrectomy-induced CKD and Sham-operated rats were divided as follows: CKD and Sham received a standard diet and CKD-BN and Sham-BN received a 5% Brazil nut enriched-diet. The protein content of glial fibrillary acid protein (GFAP), enteric glial marker, and GPx protein content and activity were assessed in the colon. The major phyla of gut microbiota were assessed. Results: CKD-BN group presented a decrease in GFAP content ( p = 0.0001). The CKD-BN group modulated the abundance of Firmicutes , increasing its proportion compared to the CKD group. The CKD-BN group showed increased GPx activity in the colon ( p = 0.0192), despite no significant difference in protein content. Conclusion: Brazil nut-enriched diet consumption decreased enteric glial reactivity and modulated gut microbiota in the CKD experimental model.
- Published
- 2024
- Full Text
- View/download PDF
12. Effects of Probiotic-Enriched Minas Cheese (Lactobacillus acidophilus La-05) on Cardiovascular Parameters in 5/6 Nephrectomized Rats.
- Author
-
da Silva Costa N, de Araujo JR, da Silva Melo MF, da Costa Mota J, Almeida PP, Coutinho-Wolino KS, Da Cruz BO, Brito ML, de Souza Carvalho T, Barreto-Reis E, de Luca BG, Mafra D, Magliano D'C, de Souza Abboud R, Rocha RS, da Cruz AG, de Toledo Guimarães J, and Stockler-Pinto MB
- Abstract
Dairy foods have become an interest in chronic kidney disease (CKD) due to their nutritional profile, which makes them a good substrate for probiotics incorporation. This study evaluated the effect of probiotic-enriched Minas cheese with Lactobacillus acidophilus La-05 in an experimental rat model for CKD on cardiac, inflammatory, and oxidative stress parameters. Male Wistar rats were divided into 4 groups (n = 7/group): 5/6 nephrectomy + conventional Minas cheese (NxC); 5/6 nephrectomy + probiotic Minas cheese (NxPC); Sham + conventional Minas cheese (ShamC); Sham + probiotic Minas cheese (ShamPC). Offering 20 g/day of Minas cheese with Lact. acidophilus La-05 (10
8 -109 log CFU/g) for 6 weeks. The cardiomyocyte diameter was determined. Superoxide dismutase (SOD) activity in plasma, heart, kidney, and colon tissue was performed. At the end of supplementation, no significant changes in lipid profile and renal parameters were found. The NxPC group showed a decrease in cardiomyocyte diameter compared to the NxC group (16.99 ± 0.85 vs. 19.05 ± 0.56 μm, p = 0.0162); also they showed reduced plasmatic SOD activity (502.8 ± 49.12 vs. 599.4 ± 94.69 U/mL, p < 0.0001). In summary, probiotic-enriched Minas cheese (Lact. acidophilus La-05) consumption suggests a promisor cardioprotective effect and was able to downregulate SOD activity in a rat model of CKD., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2023
- Full Text
- View/download PDF
13. Nanoporous YVO 4 as a luminescent host for probing molecular encapsulation.
- Author
-
Brito ML, Huband S, Walker M, Walton RI, and de Sousa Filho PC
- Abstract
Control of phase separation of VO
4 3- and rare earth precursors in reverse microemulsions afforded ∼35 nm YVO4 nanoparticles with functionalisable ∼7 ± 3 nm nanopores. Doping by Eu3+ allowed luminescent probing of interfacial crystallisation while xylenol orange absorption showed molecular encapsulation in particle cavities. This provides potential multifunctional systems combining UV-Vis-NIR luminescence and (photo)active molecules for optical sensing.- Published
- 2023
- Full Text
- View/download PDF
14. Neurocritical Patients: Review of the Scope of Nursing Diagnoses and Care in the Intensive Care Unit.
- Author
-
Peixoto Brito ML, Reis Macedo LF, de Siqueira Coelho Lisboa KW, Dos Santos Sales V, de Lima Pinto S, and Felix Silva DS
- Abstract
Objective: To identify the diagnoses and nursing care for neurocritical patients in the intensive care unit., Method: This is a scope review study, based on the Joanna Briggs Institute, led by the following guiding question: what are the diagnoses and nursing care for neurocritical patients in the intensive care unit? Data collection was carried out in February 2022 in a paired manner, in the following databases: EMBASE, MEDLINE, PubMed, and SCOPUS. For sample selection, the following search strategy was used: "Neurology" AND "Nursing Care" OR "Nursing Diagnosis" AND "Critical Care." Studies were independently selected, blinded by two reviewers., Result: It was possible to identify 854 studies, which after analysis by title and abstract, only 27 articles passed the eligibility, of which 10 were part of this review., Conclusion: According to the analysis of the studies, it was found that nursing care, combined with a care plan for neurocritical patients, allows for better results, with a view to the quality of life and health promotion., Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2023.)
- Published
- 2023
- Full Text
- View/download PDF
15. Supplementation of diet with Brazil nut modulates body composition, bone parameters, and lipid peroxidation in Wistar rats.
- Author
-
da Silva Costa N, Almeida PP, Da Cruz BO, Brito ML, Maldonado-Campos J, Menezes AC, Figueiredo MS, Magliano AC, Pereira AD, and Stockler-Pinto MB
- Subjects
- Animals, Male, Rats, Body Composition, Cholesterol, Diet, Dietary Supplements, Fatty Acids, Unsaturated, Lipid Peroxidation, Lipids, Lipoproteins, HDL, Rats, Wistar, Bertholletia, Selenium
- Abstract
Oxidative stress, adipose tissue, and bone compartments can be disturbed in chronic diseases. Non-pharmacological strategies, such as Brazil nuts (BNs), can improve these parameters. This study evaluated the effects of BN supplementation at different concentrations on body composition, lipid profile, and peroxidation in healthy rats. Male Wistar rats were divided into three groups: control (CT), Brazil nut 5% (BN5), and Brazil nut 10% (BN10) groups. Body composition, brown adipose tissue (BAT), plasma lipid peroxidation, and lipid profile were evaluated in the three groups. The BN5 group showed an improvement in all bone parameters compared with that of the CT group (p < .0001). The BN5 and BN10 groups showed reduced plasma lipid peroxidation compared with that of the CT group (p = .0009), whereas the BN10 group presented lower BAT lipid peroxidation than that of the other groups (p = .01). High-density lipoprotein-cholesterol (HDL-c) levels were higher in the BN5 group than in the CT group (p = .01). Conclusively, the use of BNs in a controlled manner promoted improvement in bone parameters, HDL-c levels, and lipid peroxidation in healthy rats. PRACTICAL APPLICATIONS: Nuts has been included in the diet because of their versatility, acceptance, and easy access. Among them, Brazil nut (BN) is considered one of the major known food sources of selenium as well as a source of fibers, unsaturated fatty acids, and phenolic compounds. Studies have shown that BN supplementation is effective in reducing oxidative stress, inflammation, lipid peroxidation, and selenium deficiency when used as a non-pharmacological strategy in experimental models of chronic diseases and in clinical trials. The present study showed that controlled administration of BN improved bone parameters, high-density lipoprotein-cholesterol levels, and lipid peroxidation in healthy rats. Therefore, BN is a promising non-pharmacological agent for the prevention of the onset of chronic non-communicable diseases., (© 2022 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
16. In vivo functional and health benefits of a prebiotic soursop whey beverage processed by high-intensity ultrasound: Study with healthy Wistar rats.
- Author
-
Guimarães JT, Almeida PP, Brito ML, Cruz BO, Costa NS, Almeida Ito RV, Mota JC, Bertolo MRV, Morais STB, Neto RPC, Tavares MIB, Souto F, Bogusz Junior S, Pimentel TC, Stockler-Pinto MB, Freitas MQ, and Cruz AG
- Subjects
- Animals, Antioxidants analysis, Beverages analysis, Prebiotics, Rats, Rats, Wistar, Annona, Whey chemistry
- Abstract
New technologies for food processing have been used to enhance the beneficial effects of foods. This study aimed to evaluate the effects of a prebiotic soursop whey beverage processed by high-intensity ultrasound (HIUS) on healthy rats. Whey beverages were processed by HIUS (20KHz, 520 W of nominal power, <53 °C, 20.3 W of acoustic power, energy density of 2.9 kJ.cm
-3 and 9.5 min to process 100 mL) and high-temperature short-time (HTST, 75 °C for 15 s) before being supplemented to Wistar rats by gavage for 15 days. Antioxidant, antidiabetic, anti-hypertensive, and anticancer activities, lipid peroxidation, bioactive peptides, and microstructure of the beverages were analyzed. In addition, the body mass, food, and water intake, systolic blood pressure, biochemical and oxidative stress parameters were measured. The sonicated beverage induced satiety, decreased glutathione peroxidase activity, total triglycerides, very-low-density lipoprotein cholesterol, and alanine aminotransferase. These findings suggest that ultrasound technology can provide in vivo health and functional benefits., (Copyright © 2022 Elsevier Ltd. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
17. 5/6 nephrectomy affects enteric glial cells and promotes impaired antioxidant defense in the colonic neuromuscular layer.
- Author
-
Almeida PP, Thomasi BBM, Menezes ÁC, Da Cruz BO, Costa NDS, Brito ML, Pereira AD, Castañon CR, Degani VAN, Magliano DC, Knauf C, Tavares-Gomes AL, and Stockler-Pinto MB
- Subjects
- Animals, Colon metabolism, Connexin 43 metabolism, Female, Glial Fibrillary Acidic Protein metabolism, Glutathione Peroxidase metabolism, Humans, Inflammation pathology, Male, Nephrectomy, Neuroglia metabolism, Rats, Superoxide Dismutase metabolism, Antioxidants metabolism, Renal Insufficiency, Chronic metabolism
- Abstract
Aims: Chronic kidney disease (CKD) produces multiple repercussions in the gastrointestinal tract (GIT), such as alterations in motility, gut microbiota, intestinal permeability, and increased oxidative stress. However, despite enteric glial cells (EGC) having important neural and immune features in GIT physiology, their function in CKD remains unknown. The present study investigates colonic glial markers, inflammation, and antioxidant parameters in a CKD model., Main Methods: A 5/6 nephrectomized rat model was used to induce CKD in rats and Sham-operated animals as a control to suppress. Biochemical measures in plasma and neuromuscular layer such as glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity were carried out. Kidney histopathology was evaluated. Colon morphology analysis and glial fibrillary acid protein (GFAP), connexin-43 (Cx43), nuclear factor-kappa B (NF-κB) p65, and GPx protein expression were performed., Key Findings: The CKD group exhibited dilated tubules and tubulointerstitial fibrosis in the reminiscent kidney (p = 0.0002). CKD rats showed higher SOD activity (p = 0.004) in plasma, with no differences in neuromuscular layer (p = 0.9833). However, GPx activity was decreased in the CKD group in plasma (p = 0.013) and neuromuscular layer (p = 0.0338). Morphological analysis revealed alterations in colonic morphometry with inflammatory foci in the submucosal layer and neuromuscular layer straightness in CKD rats (p = 0.0291). In addition, GFAP, Cx43, NF-κBp65 protein expression were increased, and GPx decreased in the neuromuscular layer of the CKD group (p < 0.05)., Significance: CKD animals present alterations in colonic cytoarchitecture and decreased layer thickness. Moreover, CKD affects the enteric glial network of the neuromuscular layer, associated with decreased antioxidant activity and inflammation., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
18. Correction to: Complementary feeding methods in the first year of life: a study protocol for a randomized clinical trial.
- Author
-
Nunes LM, Führ J, Belin CHS, Moreira PR, Neves RO, de Brito ML, Morando LA, Mariath AAS, Gomes E, and Bernardi JR
- Published
- 2021
- Full Text
- View/download PDF
19. Complementary feeding methods in the first year of life: a study protocol for a randomized clinical trial.
- Author
-
Nunes LM, Führ J, Belin CHS, Moreira PR, Neves RO, de Brito ML, Morando LA, Mariath AAS, Gomes E, and Bernardi JR
- Subjects
- Feeding Behavior, Humans, Infant, Infant Nutritional Physiological Phenomena, Prospective Studies, Randomized Controlled Trials as Topic, Weaning, Dental Caries
- Abstract
Background: The traditional spoon-feeding approach to introduction of solid foods during the complementary feeding period is supported by consensus in the scientific literature. However, a method called Baby-Led Introduction to SolidS (BLISS) has been proposed as an alternative, allowing infants to self-feed with no adult interference. To date, there have been no trials in the Brazilian population to evaluate the effectiveness of BLISS in comparison to the traditional approach., Methods/design: To evaluate and compare three different complementary feeding methods. Data on 144 mother-child pairs will be randomized into intervention groups by methods: (A) strict Parent-Led Weaning; (B) strict Baby-Led Introduction to SolidS; and (C) a mixed method. Prospective participants from Porto Alegre, Brazil, and nearby cities will be recruited through the Internet. The interventions will be performed by nutritionists and speech therapists, at 5.5 months of age of the child, at a private nutrition office equipped with a test kitchen where meals will be prepared according to the randomized method. The pairs will be followed up at 7, 9, and 12 months of age. Data will be collected through questionnaires designed especially for this study, which will include a 24h child food recall, questionnaires on the child's and parents' eating behavior, oral habits, eating difficulties, and choking prevalence. At 12 months of age, children will undergo blood collection to measure hemoglobin, ferritin, and C-reactive protein, saliva collection for analysis of genetic polymorphisms, and oral examination. Anthropometric parameters (child and maternal) will be measured at the baseline intervention, at a 9 month home visit, and at the end-of-study visit at the hospital. The primary outcome will be child growth and nutritional status z-scores at 12 months; secondary outcomes will include iron status, feeding behavior, acceptability of the methods, dietary variety, choking, eating behaviors, food preferences, acceptance of bitter and sweet flavors, suction, oral habits, oral hygiene behavior, dental caries, gingival health status, and functional constipation., Discussion: The trial intends to ascertain whether there are potential advantages to the BLISS complementary feeding method in this specific population, generating data to support families and healthcare providers., Trial Registration: Brazilian Clinical Trials Registry (ReBEC): RBR- 229scm number U1111-1226-9516 . Registered on September 24, 2019., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
20. Caffeine Intake During Pregnancy in Different Intrauterine Environments and its Association with Infant Anthropometric Measurements at 3 and 6 Months of Age.
- Author
-
de Medeiros TS, Bernardi JR, de Brito ML, Bosa VL, Goldani MZ, and da Silva CH
- Subjects
- Adult, Body Weight physiology, Brazil, Caffeine administration & dosage, Central Nervous System Stimulants administration & dosage, Female, Humans, Infant, Infant, Newborn, Infant, Small for Gestational Age, Longitudinal Studies, Pregnancy, Prenatal Exposure Delayed Effects, Skinfold Thickness, Smoking adverse effects, Waist Circumference, Anthropometry, Caffeine adverse effects, Central Nervous System Stimulants adverse effects, Child Development physiology, Mothers
- Abstract
Objective To investigate the association between maternal caffeine intake during pregnancy and infant anthropometric measurements at age 3 and 6 months. Methods Longitudinal observational study of mother-child pairs stratified into five groups: diabetic women (DM), hypertensive women (HYP), smoking mothers (SMO), mothers of infants small for gestational age (SGA), and controls (CTL). Pairs were recruited from three public hospitals in Porto Alegre, Brazil, from 2011 to 2015, using a convenience sampling strategy. The Food Frequency Questionnaire (FFQ) was administered on postpartum day 7 to evaluate maternal caffeine intake during pregnancy. The anthropometric measurements of interest (weight, length, and skinfold thickness) were assessed at birth and at age 3 and 6 months. Linear regression was used to analyze the interaction between caffeine intake and skinfold thickness. Results Overall, 272 mother-child pairs were investigated (41 DM, 26 HYP, 68 SMO, 25 SGA, and 112 CTL). There were no differences in anthropometric measurements between infants born to mothers who had and had not consumed caffeine during pregnancy (P > 0.05). Children of mothers in the DM group had the highest adjusted average skinfold thicknesses at 3 months. An interaction between maternal caffeine intake during pregnancy and the sum of skinfolds at age 3 months was found in the DM and CTL groups (P < 0.05). However, significant differences were not observed at 6 months. Conclusions Maternal caffeine intake influenced infants skinfold thickness measurements at 3 months of age. This parameter was reduced in infants born to mothers with DM and increased in those born to healthy control mothers.
- Published
- 2017
- Full Text
- View/download PDF
21. Somatic growth in the first six months of life of infants exposed to maternal smoking in pregnancy.
- Author
-
de Brito ML, Nunes M, Bernardi JR, Bosa VL, Goldani MZ, and da Silva CH
- Subjects
- Adult, Birth Weight, Brazil epidemiology, Female, Fetal Growth Retardation epidemiology, Follow-Up Studies, Gestational Age, Humans, Incidence, Infant, Infant, Newborn, Male, Pregnancy, Prenatal Exposure Delayed Effects etiology, Retrospective Studies, Time Factors, Fetal Growth Retardation etiology, Infant, Low Birth Weight, Maternal Exposure adverse effects, Mothers, Prenatal Exposure Delayed Effects epidemiology, Smoking adverse effects
- Abstract
Background: Some studies suggest a relationship between maternal smoking during pregnancy and not only intrauterine fetal growth restriction or low birth weight, but also with changes in the postnatal growth and development. The objective of the present study was to investigate the effects of smoking during pregnancy on infants growth in the first 6 months of life compared with a control group and a group with idiopathic intrauterine growth restriction., Methods: Longitudinal observational study using a convenience sample of newborns divided into three groups: infants of smoking mothers (tobacco), with idiopathic intrauterine growth restriction (IUGR) and a control group. The sample was selected from two hospitals in Porto Alegre, located in southern Brazil, between 2011 and 2015. Newborns were evaluated at birth, 7 and 15 days, and in the first, third, and sixth month. Anthropometric measures were weight, length and head circumference. The growth indicators used were expressed as z-scores. The analyses were performed using the generalized estimating equation method., Results: The sample included 273 mother/newborn pairs: 86 tobacco group, 34 IUGR group, and 153 control group. In terms of weight at birth, all groups differed significantly (p < 0.001). The birth length of tobacco and control groups were similar, but the IUGR group was lower than both (p < 0.001). We found no differences in growth trajectory between tobacco and control group, but there were differences in the growth of the IUGR group when compared with the other groups. At 6 months of age, all groups had similar anthropometric measurements., Conclusion: Intrauterine growth restriction had major impact on the growth trajectory of the infants studied, regardless of other factors, such as smoking and diet.
- Published
- 2017
- Full Text
- View/download PDF
22. Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
- Author
-
Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Barreira AA, Brooks JB, Claudino R, Correa EC, Ferreira ML, Finkelsztejn A, Finkelsztejn J, da Gama PD, Goncalves MV, Guerreiro CT, da Cunha Matta AP, Marques VD, Rizo Morales R, Parolin MF, de Castro Ribeiro M, Ribeiro TA, Ruocco HH, Sato H, Scherpenhuijzen S, Siquineli F, de Carvalho Sousa NA, Varela DL, Tauil CB, and Winckler TC
- Subjects
- 4-Aminopyridine pharmacology, Adult, Aged, Female, Gait Disorders, Neurologic epidemiology, Humans, Life Change Events, Male, Middle Aged, Multiple Sclerosis epidemiology, Potassium Channel Blockers pharmacology, Prospective Studies, 4-Aminopyridine therapeutic use, Gait Disorders, Neurologic diagnosis, Gait Disorders, Neurologic drug therapy, Multiple Sclerosis diagnosis, Multiple Sclerosis drug therapy, Potassium Channel Blockers therapeutic use
- Abstract
Background: Fampridine is a broad-spectrum voltage-dependent potassium channel blocker that enhances synaptic transmission. The drug has been shown to be able to ameliorate conduction in demyelinated axons, thereby leading to improved gait in patients with multiple sclerosis (MS)., Objective: To assess the "real-life" efficacy and safety of fampridine prescribed for gait disorders in MS. This was an observational and prospective study carried out at MS Units participating in the Brazilian Multiple Sclerosis Study Group., Methods: Patients with MS and gait disorders were prescribed fampridine (10 mg twice a day), irrespectively of the degree of disability determined by MS. Neurological disability determined by MS was assessed with the expanded disability scale score (EDSS). Outcomes for efficacy and safety of the drug were evaluated by the 25 foot-walk test and by the adverse events of fampridine., Results: The time taken to walk 25 feet decreased by 20% or more in 62 patients (70%). Twenty-five patients were considered to be non-responders to this treatment. Improvement in walking speed was independent of improvement of disability. Mild or moderate adverse events were reported in 8% of patients., Conclusion: Fampridine is an efficient and safe therapeutic option for patients with MS and gait disorders.
- Published
- 2016
- Full Text
- View/download PDF
23. Guillain-Barré syndrome associated with the Zika virus outbreak in Brazil.
- Author
-
Araujo LM, Ferreira ML, and Nascimento OJ
- Subjects
- Brazil epidemiology, Guillain-Barre Syndrome epidemiology, Humans, Incidence, Zika Virus Infection epidemiology, Disease Outbreaks, Guillain-Barre Syndrome virology, Zika Virus Infection complications
- Abstract
Zika virus (ZIKV) is now considered an emerging flavivirosis, with a first large outbreak registered in the Yap Islands in 2007. In 2013, a new outbreak was reported in the French Polynesia, with associated cases of neurological complications including Guillain-Barré syndrome (GBS). The incidence of GBS has increased in Brazil since 2015, what is speculated to be secondary to the ZIKV infection outbreak. The gold-standard test for detection of acute ZIKV infection is the polymerase-chain reaction technique, an essay largely unavailable in Brazil. The diagnosis of GBS is feasible even in resource-limited areas using the criteria proposed by the GBS Classification Group, which is based solely on clinical grounds. Further understanding on the relationship of ZIKV with neurological complications is a research urgency.
- Published
- 2016
- Full Text
- View/download PDF
24. Depression and anxiety in individuals with amyotrophic lateral sclerosis: a systematic review.
- Author
-
Carvalho TL, de Almeida LM, Lorega CM, Barata MF, Ferreira ML, de Brito-Marques PR, and Correia Cda C
- Subjects
- Humans, Amyotrophic Lateral Sclerosis epidemiology, Amyotrophic Lateral Sclerosis psychology, Anxiety epidemiology, Depression epidemiology
- Abstract
Introduction: Studies assessing symptoms of depression and anxiety in individuals with amyotrophic lateral sclerosis (ALS) have reported contradictory results. The objective of this systematic review is to identify the prevalence of these mood disorders in the literature., Methods: We searched the PubMed, HighWire, MEDLINE, SciELO, LILACS and ScienceDirect databases. Literature was selected for review in two stages, according to eligibility criteria. The first stage involved searching databases and checking titles and abstracts. The second step consisted of reading complete articles and excluding those that did not meet the inclusion criteria. The inclusion criteria were articles written in Portuguese, English or Spanish, published in the last five years and involving people with ALS diagnosed according to the El Escorial criteria., Results: The database searches returned a total of 1,135 titles and abstracts and then 1,117 of these were excluded. Eighteen articles were selected for review. The 12-item Amyotrophic Lateral Sclerosis Depression Inventory (ADI-12) was the only instrument designed specifically to assess depression in ALS, but it was only used in three studies. No instruments specifically designed for anxiety in ALS were used. A large number of studies found presence and slight increase of anxiety disorders. There was considerable large variation in the results related to depressive disorders, ranging from moderate depression to an absence of symptoms., Conclusions: Patients with ALS may exhibit symptoms of depression and anxiety at different levels, but there is a need for studies using specific instruments with larger samples in order to ascertain the prevalence of symptoms in ALS and the factors associated with it.
- Published
- 2016
- Full Text
- View/download PDF
25. Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
- Author
-
Papais-Alvarenga RM, Vasconcelos CC, Carra A, de Castillo IS, Florentin S, Diaz de Bedoya FH, Mandler R, de Siervi LC, Pimentel ML, Alvarenga MP, Alvarenga MP, Grzesiuk AK, Gama Pereira AB, Gomes Neto AP, Velasquez C, Soublette C, Fleitas CV, Diniz DS, Armas E, Batista E, Hernandez F, Pereira FF, Siqueira HH, Cabeça H, Sanchez J, Brooks JB, Gonçalves MV, Barroso MC, Ravelo ME, Castillo MC, Ferreira ML, Rocha MS, Parolin MK, Molina O, Marinho PB, Christo PP, Brant de Souza R, Pessanha Neto S, Camargo SM, Machado SC, Neri VC, Fragoso YD, Alvarenga H, and Thuler LC
- Subjects
- Adolescent, Adult, Age Factors, Aged, Animals, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Infant, Male, Mice, Middle Aged, Multiple Sclerosis diagnosis, Multiple Sclerosis therapy, Neuromyelitis Optica diagnosis, Neuromyelitis Optica therapy, Sex Factors, South America epidemiology, South America ethnology, Multiple Sclerosis ethnology, Multiple Sclerosis mortality, Neuromyelitis Optica ethnology, Neuromyelitis Optica mortality
- Abstract
The idiopathic inflammatory demyelinating disease (IIDD) spectrum has been investigated among different populations, and the results have indicated a low relative frequency of neuromyelitis optica (NMO) among multiple sclerosis (MS) cases in whites (1.2%-1.5%), increasing in Mestizos (8%) and Africans (15.4%-27.5%) living in areas of low MS prevalence. South America (SA) was colonized by Europeans from the Iberian Peninsula, and their miscegenation with natives and Africans slaves resulted in significant racial mixing. The current study analyzed the IIDD spectrum in SA after accounting for the ethnic heterogeneity of its population. A cross-sectional multicenter study was performed. Only individuals followed in 2011 with a confirmed diagnosis of IIDD using new diagnostic criteria were considered eligible. Patients' demographic, clinical and laboratory data were collected. In all, 1,917 individuals from 22 MS centers were included (73.7% female, 63.0% white, 28.0% African, 7.0% Mestizo, and 0.2% Asian). The main disease categories and their associated frequencies were MS (76.9%), NMO (11.8%), other NMO syndromes (6.5%), CIS (3.5%), ADEM (1.0%), and acute encephalopathy (0.4%). Females predominated in all main categories. The white ethnicity also predominated, except in NMO. Except in ADEM, the disease onset occurred between 20 and 39 years old, early onset in 8.2% of all cases, and late onset occurred in 8.9%. The long-term morbidity after a mean disease time of 9.28±7.7 years was characterized by mild disability in all categories except in NMO, which was scored as moderate. Disease time among those with MS was positively correlated with the expanded disability status scale (EDSS) score (r=0.374; p=<0.001). This correlation was not observed in people with NMO or those with other NMO spectrum disorders (NMOSDs). Among patients with NMO, 83.2% showed a relapsing-remitting course, and 16.8% showed a monophasic course. The NMO-IgG antibody tested using indirect immunofluorescence (IIF) with a composite substrate of mouse tissues in 200 NMOSD cases was positive in people with NMO (95/162; 58.6%), longitudinally extensive transverse myelitis (10/30; 33.3%) and bilateral or recurrent optic neuritis (8/8; 100%). No association of NMO-IgG antibody positivity was found with gender, age at onset, ethnicity, early or late onset forms, disease course, or long-term severe disability. The relative frequency of NMO among relapsing-remitting MS (RRMS) + NMO cases in SA was 14.0%. Despite the high degree of miscegenation found in SA, MS affects three quarters of all patients with IIDD, mainly white young women who share similar clinical characteristics to those in Western populations in the northern hemisphere, with the exception of ethnicity; approximately one-third of all cases occur among non-white individuals. At the last assessment, the majority of RRMS patients showed mild disability, and the risk for secondary progression was significantly superior among those of African ethnicity. NMO comprises 11.8% of all IIDD cases in SA, affecting mostly young African-Brazilian women, evolving with a recurrent course and causing moderate or severe disability in both ethnic groups. The South-North gradient with increasing NMO and non-white individuals from Argentina, Paraguay, Brazil and Venezuela confirmed previous studies showing a higher frequency of NMO among non-white populations.
- Published
- 2015
- Full Text
- View/download PDF
26. Neuropeptide Y administration reverses tricyclic antidepressant treatment-resistant depression induced by ACTH in mice.
- Author
-
Antunes MS, Ruff JR, de Oliveira Espinosa D, Piegas MB, de Brito ML, Rocha KA, de Gomes MG, Goes AT, Souza LC, Donato F, Boeira SP, and Jesse CR
- Subjects
- Animals, Corticosterone blood, Depressive Disorder blood, Disease Models, Animal, Female, Hippocampus drug effects, Hippocampus metabolism, Hydroxyindoleacetic Acid blood, Indoleamine-Pyrrole 2,3,-Dioxygenase metabolism, Mice, Mice, Inbred C57BL, Neuropeptide Y administration & dosage, Swimming physiology, Adrenocorticotropic Hormone, Antidepressive Agents, Tricyclic therapeutic use, Depressive Disorder chemically induced, Depressive Disorder drug therapy, Drug Resistance drug effects, Neuropeptide Y pharmacology
- Abstract
Depression is one of the most common mental disorders and a primary cause of disability. To better treat patients suffering this illness, elucidation of the underlying psychopathological and neurobiological mechanisms is urgently needed. Based on the above-mentioned evidence, we sought to investigate the effects of neuropeptide Y (NPY) treatment in tricyclic antidepressant treatment-resistant depression induced by adrenocorticotropic hormone (ACTH) administration. Mice were treated with NPY (5.84, 11.7 or 23.4mmol/μl) intracerebroventricularly (i.c.v.) for one or five days. The levels of serum corticosterone, tryptophan (TRP), kynurenine (KYN), serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF) and indoleamine 2,3-dioxygenase (IDO) activity in the hippocampus were analyzed. The behavioral parameters (depressive-like and locomotor activity) were also verified. This study demonstrated that ACTH administration increased serum corticosterone levels, KYN, 5-HIAA levels, IDO activity (hippocampus), immobility in the forced swimming test (FST) and the latency to feed in the novelty suppressed feeding test (NSFT). In addition, ACTH administration decreased the BDNF and NGF levels in the hippocampus of mice. NPY treatment was effective in preventing these hormonal, neurochemical and behavioral alterations. It is suggested that the main target of NPY is the modulation of corticosterone and neuronal plasticity protein levels, which may be closely linked with pharmacological action in a model of tricyclic antidepressant treatment-resistant depression. Thus, this study demonstrated a protective effect of NPY on the alterations induced by ACTH administration in mice, indicating that it could be useful as a therapy for the treatment of tricyclic antidepressant treatment-resistant depression., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
27. Vector competence of the Aedes aegypti population from Santiago Island, Cape Verde, to different serotypes of dengue virus.
- Author
-
da Moura AJ, de Melo Santos MA, Oliveira CM, Guedes DR, de Carvalho-Leandro D, da Cruz Brito ML, Rocha HD, Gómez LF, and Ayres CF
- Subjects
- Animals, Cabo Verde epidemiology, Cell Line, Dengue virology, Dengue Virus genetics, Dengue Virus physiology, Female, Humans, Islands, Male, RNA, Viral genetics, Salivary Glands virology, Virus Replication, Aedes virology, Antigens, Viral immunology, Dengue transmission, Dengue Virus immunology, Insect Vectors virology
- Abstract
Background: Dengue is an arboviral disease caused by dengue virus (DENV), whose main vectors are the mosquitoes Aedes aegypti and Aedes albopictus. A. aegypti is the only DENV vector in Cape Verde, an African country that suffered its first outbreak of dengue in 2009. However, little is known about the variation in the level of vector competence of this mosquito population to the different DENV serotypes. This study aimed to evaluate the vector competence of A. aegypti from the island of Santiago, Cape Verde, to four DENV serotypes and to detect DENV vertical transmission., Methods: Mosquitoes were fed on blood containing DENV serotypes and were dissected at 7, 14 and 21 days post-infection (dpi) to detect the virus in the midgut, head and salivary glands (SG) using RT-PCR. Additionally, the number of copies of viral RNA present in the SG was determined by qRT-PCR. Furthermore, eggs were collected in the field and adult mosquitoes obtained were analyzed by RT-PCR and the platelia dengue NS1 antigen kit to detect transovarial transmission., Results: High rates of SG infection were observed for DENV-2 and DENV-3 whereas for DENV-1, viral RNA was only detected in the midgut and head. DENV-4 did not spread to the head or SG, maintaining the infection only in the midgut. The number of viral RNA copies in the SG did not vary significantly between DENV-2 and DENV-3 or among the different periods of incubation and the various titers of DENV tested. With respect to DENV surveillance in mosquitoes obtained from the eggs collected in the field, no samples were positive., Conclusion: Although no DENV positive samples were collected from the field in 2014, it is important to highlight that the A. aegypti population from Santiago Islands exhibited different degrees of susceptibility to DENV serotypes. This population showed a high vector competence for DENV-2 and DENV-3 strains and a low susceptibility to DENV-1 and DENV-4. Viral RNA copies in the SG remained constant for at least 21 dpi, which may enhance the vector capacity of A. aegypti and suggests the presence of a mechanism modulating virus replication in the SG.
- Published
- 2015
- Full Text
- View/download PDF
28. Natalizumab treatment for multiple sclerosis.
- Author
-
Ferreira ML
- Subjects
- Female, Humans, Natalizumab, Antibodies, Monoclonal, Humanized adverse effects, Immunosuppressive Agents adverse effects, JC Virus immunology, Leukoencephalopathy, Progressive Multifocal virology, Multiple Sclerosis drug therapy, Multiple Sclerosis immunology
- Published
- 2014
- Full Text
- View/download PDF
29. Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D.
- Author
-
Fragoso YD, Adoni T, Damasceno A, de Albuquerque Damasceno CA, Ferreira ML, Finkelzstejn A, Gomes S, Goncalves MV, Grzesiuk AK, Lins S, Mendes MF, de Oliveira FT, Parolin MF, Rocha CF, and Tauil CB
- Subjects
- Humans, Hypercalcemia blood, Multiple Sclerosis, Relapsing-Remitting blood, Nephrolithiasis blood, Treatment Failure, Vitamin D therapeutic use, Hypercalcemia chemically induced, Multiple Sclerosis, Relapsing-Remitting drug therapy, Nephrolithiasis chemically induced, Vitamin D adverse effects
- Published
- 2014
- Full Text
- View/download PDF
30. How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?
- Author
-
Fragoso YD, Adoni T, Anacleto A, Brooks JB, Carvalho Mde J, Claudino R, Damasceno A, Ferreira ML, Gama PD, Goncalves MV, Grzesiuk AK, Matta AP, and Parolin MF
- Subjects
- Disease Management, Humans, Immunosuppressive Agents adverse effects, Immunosuppressive Agents therapeutic use, Multiple Sclerosis drug therapy, Tuberculosis etiology
- Abstract
Tuberculosis continues to be a serious health problem worldwide. The disease continues to be underdiagnosed and not properly treated. In conditions that affect the immune system, such as multiple sclerosis (MS), latent tuberculosis may thrive and reactivate during the use of immunomodulatory and immunosuppressive drugs. Among the best treatment options for patients with latent or active tuberculosis who have MS are IFN-β, glatiramer acetate and mitoxantrone. Drugs leading to a reduced number and/or function of lymphocytes should be avoided or used with caution. Tuberculosis must always be investigated in patients with MS and treated with rigor.
- Published
- 2014
- Full Text
- View/download PDF
31. Multiple sclerosis starting before the age of 18 years: the Brazilian experience.
- Author
-
Fragoso YD, Ferreira ML, Morales Nde M, Arruda WO, Brooks JB, Carneiro DS, Carvalho Mde J, Comini-Frota ER, Correa EC, Damasceno CA, Domingues RB, Finkelsztejn A, Gama PD, Gomes S, Gonçalves MV, Grzesiuk AK, Khouri JM, Kaimen-Maciel DR, Mendes MF, Morales Rde R, Ribeiro SB, Ribeiro TA, Albuquerque LB, Anacleto A, Finkelsztejn J, Gama RA, Lopes J, Oliveira CL, Oliveira FT, Pires LA, Saldanha PC, Souza AH, and Silva AE
- Subjects
- Adolescent, Age Distribution, Age of Onset, Brazil epidemiology, Child, Child, Preschool, Disease Progression, Female, Humans, Male, Multiple Sclerosis diagnosis, Multiple Sclerosis therapy, Retrospective Studies, Sex Distribution, Time Factors, Multiple Sclerosis epidemiology
- Abstract
Multiple sclerosis (MS) starting in childhood and adolescence poses a challenge for diagnosis and management of the disease. The aim of the present study was to assess the characteristics of early onset MS in Brazilian patients. Methods Retrospective data collection from specialized MS units. Results From 20 MS units in 11 Brazilian states, 117 cases of MS starting before the age of 18 years were collected. These patients had an average of 10 years of disease duration, still typically with low disability and one relapse every 2.5 years. The mean age for disease onset was 13.7 years. Conclusion The present study introduces a large series of Brazilian cases of pediatric MS. Although some patients presented a very severe form of MS, on the whole the group of patients with MS starting in childhood or adolescence presented a relatively mild form of this disease in Brazil.
- Published
- 2013
- Full Text
- View/download PDF
32. Neuromyelitis optica and pregnancy.
- Author
-
Fragoso YD, Adoni T, Bichuetti DB, Brooks JB, Ferreira ML, Oliveira EM, Oliveira CL, Ribeiro SB, Silva AE, and Siquineli F
- Subjects
- Adult, Brazil epidemiology, Databases, Factual statistics & numerical data, Disability Evaluation, Disease Progression, Female, Humans, Neuromyelitis Optica diagnosis, Pregnancy, Recurrence, Neuromyelitis Optica epidemiology, Pregnancy Complications epidemiology, Pregnancy Complications physiopathology
- Abstract
Less than a hundred cases of pregnancies in women with neuromyelitis optica (NMO) have been published in the world. The aim of the present study was to add the Brazilian experience to this subject. Cases of women with NMO who became pregnant, or who developed NMO soon after pregnancy, were included. Retrospective analysis of medical data from these patients was carried out by the neurologist responsible for the case. Seventeen cases of pregnancies (16 full-term pregnancies, one miscarriage) were identified. The relapse rate of demyelinating events in the first trimester after pregnancy was significantly higher than at any other time. Disability progression was significantly worse 1 year after delivery. Pregnancy negatively influenced the disease course of NMO in these women. These results are similar to those of other authors, although the total number of cases so far described is still small. Obstetricians must be aware of the potential complications of a pregnancy in a woman who has NMO.
- Published
- 2013
- Full Text
- View/download PDF
33. Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
- Author
-
Fragoso YD, Mendes MF, Arruda WO, Becker J, Brooks JB, Carvalho Mde J, Comini-Frota ER, Domingues RB, Ferreira ML, Finkelsztejn A, Gama PD, Gomes S, Gonçalves MV, Kaimen-Maciel DR, Morales Rde R, Muniz A, Ruocco HH, Salgado PR, Albuquerque LB, Gama RA, Georgeto S, Lopes J, Oliveira CL, Oliveira FT, Safanelli J, Saldanha PC, and Satomi M
- Subjects
- Adult, Brazil epidemiology, Female, Humans, JC Virus immunology, Leukoencephalopathy, Progressive Multifocal epidemiology, Male, Middle Aged, Multiple Sclerosis virology, Natalizumab, Real-Time Polymerase Chain Reaction, Risk Factors, Antibodies, Monoclonal, Humanized adverse effects, DNA, Viral analysis, JC Virus genetics, Leukoencephalopathy, Progressive Multifocal chemically induced, Multiple Sclerosis drug therapy
- Abstract
Objective: Natalizumab is a new and efficient treatment for multiple sclerosis (MS). The risk of developing progressive multifocal leukoencephalopathy (PML) during the use of this drug has created the need for better comprehension of JC virus (JCV) infection. The objective of the present study was to assess the prevalence of JCV-DNA in Brazilian patients using natalizumab., Method: Qualitative detection of the JCV in the serum was performed with real-time polymerase chain reaction (PCR)., Results: In a group of 168 patients with MS who were undergoing treatment with natalizumab, JCV-DNA was detectable in 86 (51.2%) patients., Discussion: Data on JCV-DNA in Brazil add to the worldwide assessment of the prevalence of the JCV in MS patients requiring treatment with natalizumab.
- Published
- 2013
- Full Text
- View/download PDF
34. Proton magnetic spectroscopy agreed better with magnetic resonance image to lateralization of epileptogenic zone than with surface electroencephalography.
- Author
-
Leite RA, Otaduy MC, Silva GE, Ferreira ML, and Aragão Mde F
- Subjects
- Adolescent, Adult, Aspartic Acid analogs & derivatives, Aspartic Acid analysis, Brain Chemistry, Choline analysis, Creatine analysis, Cross-Sectional Studies, Epilepsies, Partial physiopathology, Female, Functional Laterality, Humans, Male, Middle Aged, Young Adult, Electroencephalography methods, Epilepsies, Partial pathology, Magnetic Resonance Imaging methods, Magnetic Resonance Spectroscopy
- Abstract
Objective: To analyze the agreement rate of proton magnetic spectroscopy with magnetic resonance image (MRI) and surface electroencephalography (EEG) in extratemporal neocortical epilepsies., Methods: A cross-sectional study, type series of cases included 33 patients, age range 13-59 years old, of both gender, presenting structural alteration identified by MRI (75.8%) or by neurophysiologic techniques (72.7%). The variables were alterations of N-acetyl-aspartate/choline, N-acetyl-aspartate/creatine, choline/creatine, and N-acetyl-aspartate/cho-line+creatine coefficient of asymmetry., Results: Agreement rates of lateralization by coefficient of asymmetry of NAA/Cho, NAA/Cr, Co/Cr, and NAA/Cho+Cr with MRI, independent of alteration of surface EEG, were equal to 93.3, 57.9, 15.4, and 93.3%, respectively, modifying to 100, 33.3, 0, and 100%, in 16 patients, with lateralization agreement of MRI and surface EEG., Conclusion: Proton magnetic spectroscopy agreed better with MRI to lateralization of epileptogenic zone than with surface EEG.
- Published
- 2013
- Full Text
- View/download PDF
35. Comparing neuromyelitis optica and multiple sclerosis severity: is there a difference?
- Author
-
Ferreira ML
- Subjects
- Aquaporin 4 immunology, Humans, Neuromyelitis Optica immunology, Severity of Illness Index, Multiple Sclerosis pathology, Neuromyelitis Optica pathology
- Published
- 2013
- Full Text
- View/download PDF
36. Natalizumab adverse events are rare in patients with multiple sclerosis.
- Author
-
Fragoso YD, Alves-Leon SV, Arruda WO, Carvalho Mde J, Comini-Frota ER, Corrêa ÉC, Ferreira ML, Gama PD, Gomes S, Gonçalves MV, Kaimen-Maciel DR, Mendes MF, Morales RR, Muniz A, Salgado PR, Ruocco HH, Albuquerque LB, Brooks JB, Fêzer L, Georgetto S, Lopes J, Malfetano FR, Meira ID, Oliveira CL, Oliveira FT, Safanelli F, and Satomi M
- Subjects
- Adolescent, Adult, Brazil, Female, Humans, Male, Middle Aged, Natalizumab, Retrospective Studies, Young Adult, Antibodies, Monoclonal, Humanized adverse effects, Multiple Sclerosis drug therapy
- Abstract
Objective: To assess the prevalence and the profile of adverse events (AE) of natalizumab in patients with multiple sclerosis (MS)., Methods: Data collection from neurologists attending to patients with MS at specialized units in Brazil., Results: Data from 103 patients attending the infusion centers of 16 MS units in 9 Brazilian states were included in the study. The total number of infusions was 1,042. Seventy-nine patients (76.7%) did not present any AE. Twenty-four patients (23.3%) presented only mild AE. There were three major AE, including two deaths. These three occurrences, although not necessarily being drug-related, must be taken into consideration., Conclusion: The profile of AEs for natalizumab shows that 97% of patients have none or only mild AE. However, still due to safety worries, the use of this medication should be restricted to MS units under the care of specialized neurologists.
- Published
- 2013
- Full Text
- View/download PDF
37. The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
- Author
-
Fragoso YD, Boggild M, Macias-Islas MA, Carra A, Schaerer KD, Aguayo A, de Almeida SM, Alvarenga MP, Alvarenga RM, Alves-Leon SV, Arruda WO, Brooks JB, Comini-Frota ER, Ferreira ML, Finkelsztejn A, Finkelsztejn JM, de Freitas LD, Gallina AS, da Gama PD, Georgetto S, Giacomo MC, Gomes S, Gonçalves MV, Grzesiuk AK, Kaimen-Maciel DR, Lopes J, Lourenco GA, Malfetano FR, Morales NM, Morales Rde R, Oliveira CL, Onaha P, Patroclo C, Ribeiro SB, Ribeiro TA, Salminen HJ, Santoro P, Seefeld M, Soares PV, Tarulla A, and Vasconcelos CC
- Subjects
- Adult, Argentina, Brazil, Breast Feeding, Cesarean Section, Databases, Factual, Delivery, Obstetric, Disease Progression, Female, Glatiramer Acetate, Humans, Infant, Newborn, Infant, Newborn, Diseases chemically induced, Infant, Newborn, Diseases epidemiology, Interferons adverse effects, Male, Mexico, Obstetric Labor Complications epidemiology, Peptides adverse effects, Pregnancy, Recurrence, Retrospective Studies, United Kingdom, Immunologic Factors adverse effects, Immunologic Factors therapeutic use, Multiple Sclerosis complications, Multiple Sclerosis drug therapy, Pregnancy Complications
- Abstract
Background and Objective: Women with multiple sclerosis (MS) who intend to get pregnant are often advised to discontinue disease modifying therapy (DMT) prior to conception. This recommendation is not based on medical evidence and may interfere with disease control by immunomodulatory drugs. The present study was designed to help discuss the effect of DMT for MS on pregnancy and on disease course., Patients and Methods: Retrospective data from 152 pregnancies of 132 women with MS were collected by the physician in charge of the case. All data were entered into a specific file for qualitative and quantitative statistical analysis., Results: From the total group of patients, 89 pregnancies occurred without any exposure to MS drugs, while 61 pregnancies occurred with at least eight weeks of exposure to MS immunomodulatory drugs. The rate of obstetric and neonatal complications was similar in both groups, except for the newborn weight and height which was smaller for mothers receiving medications. Mothers' post-delivery relapse rate and EDSS scores in the follow-up period were significantly higher in the absence of treatment., Conclusion: It is possible that, with further such supportive data, international guidelines on MS treatment in young women who intend to get pregnant may need to be revised., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
38. European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil.
- Author
-
Brum DG, Luizon MR, Santos AC, Lana-Peixoto MA, Rocha CF, Brito ML, de Oliveira EM, Bichuetti DB, Gabbai AA, Diniz DS, Kaimen-Maciel DR, Comini-Frota ER, Vieira Wiezel CE, Muniz YC, da Silva Costa RM, Mendes-Junior CT, Donadi EA, Barreira AA, and Simões AL
- Subjects
- Adult, Brazil epidemiology, Ethnicity genetics, Female, Gene Frequency, Genetic Markers, Humans, Male, Middle Aged, Multiple Sclerosis ethnology, Multiple Sclerosis genetics, Neuromyelitis Optica ethnology, Neuromyelitis Optica genetics, Young Adult, Multiple Sclerosis epidemiology, Neuromyelitis Optica epidemiology
- Abstract
Background: Neuromyelitis optica (NMO) is considered relatively more common in non-Whites, whereas multiple sclerosis (MS) presents a high prevalence rate, particularly in Whites from Western countries populations. However, no study has used ancestry informative markers (AIMs) to estimate the genetic ancestry contribution to NMO patients., Methods: Twelve AIMs were selected based on the large allele frequency differences among European, African, and Amerindian populations, in order to investigate the genetic contribution of each ancestral group in 236 patients with MS and NMO, diagnosed using the McDonald and Wingerchuck criteria, respectively. All 128 MS patients were recruited at the Faculty of Medicine of Ribeirão Preto (MS-RP), Southeastern Brazil, as well as 108 healthy bone marrow donors considered as healthy controls. A total of 108 NMO patients were recruited from five Neurology centers from different Brazilian regions, including Ribeirão Preto (NMO-RP)., Principal Findings: European ancestry contribution was higher in MS-RP than in NMO-RP (78.5% vs. 68.7%) patients. In contrast, African ancestry estimates were higher in NMO-RP than in MS-RP (20.5% vs. 12.5%) patients. Moreover, principal component analyses showed that groups of NMO patients from different Brazilian regions were clustered close to the European ancestral population., Conclusions: Our findings demonstrate that European genetic contribution predominates in NMO and MS patients from Brazil.
- Published
- 2013
- Full Text
- View/download PDF
39. Extensive spinal cord involvement in magnetic resonance imaging evaluation on schistosomal myelitis.
- Author
-
Vidal CH, Ferreira ML, Azevedo Filho HR, Gurgel FV, and Brainer-Lima AM
- Subjects
- Adolescent, Adult, Cross-Sectional Studies, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Young Adult, Neuroschistosomiasis pathology, Spinal Cord pathology
- Abstract
Unlabelled: The diagnosis of schistosomal myelitis (SM) is frequently presumptive because no findings from any complementary examination are pathognomonic for this disease. The present report describes some abnormalities seen on magnetic resonance imaging (MRI) evaluation of a series of SM patients and discusses their etiopathogenesis., Methods: This study evaluated SM patients at the time of their diagnosis. These patients routinely underwent MRI on all segments of the spinal cord., Results: Thirteen patients were evaluated. The MRI was abnormal in 12 (92.3%) of them. In 11 patients (84.61%), the damage reached two or more spinal segments., Conclusions: MRI was an important diagnostic aid in this sample, because of the high rate of abnormalities detected. The tissue damage observed on MRI was extensive in the majority of the patients.
- Published
- 2012
- Full Text
- View/download PDF
40. Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia.
- Author
-
Lakhwani S, Raya JM, González-Brito G, Álvarez-Argüelles H, Brito ML, and Hernández-Nieto L
- Subjects
- Adult, Antineoplastic Combined Chemotherapy Protocols, Enterocolitis, Pseudomembranous complications, Enterocolitis, Pseudomembranous diagnosis, Enterocolitis, Pseudomembranous drug therapy, Humans, Idarubicin therapeutic use, Leukemia, Promyelocytic, Acute complications, Leukemia, Promyelocytic, Acute drug therapy, Male, Mercaptopurine administration & dosage, Methotrexate administration & dosage, Necrosis, Recovery of Function, Remission Induction, Tretinoin therapeutic use, Vancomycin therapeutic use, Bone Marrow Cells pathology, Leukemia, Promyelocytic, Acute diagnosis, Tretinoin adverse effects
- Published
- 2011
- Full Text
- View/download PDF
41. Radicular dysfunction preponderance at early phase clinical evaluation in myelitis by Schistosoma mansoni.
- Author
-
Vidal CH, Silva JC, Souza JJ, Bernardino SP, and Ferreira ML
- Subjects
- Adolescent, Adult, Animals, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Neuroschistosomiasis parasitology, Young Adult, Neuroschistosomiasis physiopathology, Schistosomiasis mansoni physiopathology
- Abstract
Unlabelled: In neuroschistosomiasis, the spinal cord is the most common place of the disease. In high prevalent areas for schistosomiasis mansoni, the clinical alertness is important for an early diagnostic, in order to decrease the final neurological damage. This study provides some useful neurologic information about a series of patients with schistosomal myelitis., Method: The sample consisted of 13 schistosomiasis mansoni carriers examined at the moment of the diagnosis of myelitis., Results: The classical triad (lumbago, weakness at the lower limbs and urinary dysfunctions) was documented in 11 (86.61%) patients. The distribution of the clinical forms was: myeloradicular in six patients (46.15%), radicular in four (30.76%) and myelitic in three (23.07%)., Conclusion: The radicular dysfunction and their clinical associated forms were the most prominent pattern during the early phase of this disease.
- Published
- 2011
- Full Text
- View/download PDF
42. Cognitive deficits in multiple sclerosis: a systematic review.
- Author
-
Ferreira ML
- Subjects
- Humans, Neuropsychological Tests, Prospective Studies, Retrospective Studies, Cognition Disorders diagnosis, Cognition Disorders etiology, Multiple Sclerosis complications
- Abstract
Objective: To present the results of prospective and retrospective studies on multiple sclerosis patients cognitive dysfunctions, as well as to discuss the batteries of neuropsychological tests used in these investigations., Method: A systematic review was performed involving 40 studies published from 1997 to 2009, in PubMed, Scopus, Ovid, ISI Web of Knowledge, Scientific Electronic Library on line (Scielo) and Latin-American and Caribbean Center of Health Sciences Informations database. Clear description of multiple sclerosis patients cognitive deficits evaluation, study design, sample size; inclusion-exclusion and discontinuation criteria; instruments for neuropsychological evaluation, diagnostic methods, evaluated functions and detailed statistical analysis had been the inclusion criteria., Results: There is consensus on cognitive impairment of multiple sclerosis patients, especially on memory, speed processing, executive function, attention and concentration domains. One has identified use of 23 batteries and 74 neuropsychological tests, despite the recommendation of Consortium of Multiple Sclerosis Centers to the application of MACFIMS battery., Considerations: The absence of the uniformization for multiple sclerosis patients cognitive evaluation battery has precluded to achieve evidences to recommend its incorporation on diagnostic routine. Nevertheless this tendency is already outlined.
- Published
- 2010
- Full Text
- View/download PDF
43. Epidemiological aspects in neuroschistosomiasis.
- Author
-
Vidal CH, Gurgel FV, Ferreira ML, and Azevedo-Filho HR
- Subjects
- Adolescent, Adult, Brazil epidemiology, Female, Humans, Male, Middle Aged, Urbanization, Young Adult, Endemic Diseases, Neuroschistosomiasis epidemiology
- Abstract
Unlabelled: The urbanization process of schistosomiasis has been described in the literature. The present report shows and discusses some epidemiological aspects of neuroschistosomiasis that emphasizes this trend., Method: The study was done between July, 2005 and June, 2006, and consisted of spinal cord schistosomiasis carriers at the moment of diagnosis. These patients were evaluated whatever the origin and period of the year that they developed the symptoms., Results: A total of 13 patients were evaluated. Ten cases (76.92%) came from the Metropolitan Region of Recife, while the other zones (Zona da Mata, Agreste e Sertão) contributed with just three cases (23.07%). October, November and December (post rainy period) concentrated the majority of the cases (61.54%)., Conclusion: The high spatial and temporal concentration of cases in relation to a recent endemic area for Schistosomiasis suggests that the immunological status may be an important factor for installation of Sschistosomal myelitis.
- Published
- 2010
- Full Text
- View/download PDF
44. Portal Doppler ultrasound evaluation in myelitis by Schistosoma mansoni.
- Author
-
Vidal CH, Gurgel FV, Ferreira ML, Coutinho AL, and Azevedo Filho HR
- Subjects
- Adolescent, Adult, Aged, Blood Flow Velocity, Case-Control Studies, Female, Humans, Male, Middle Aged, Myelitis parasitology, Portal Vein physiopathology, Ultrasonography, Doppler, Young Adult, Myelitis diagnostic imaging, Neuroschistosomiasis diagnostic imaging, Portal Vein diagnostic imaging, Schistosomiasis mansoni diagnostic imaging
- Abstract
Unlabelled: The mechanism for development of schistosomal myelitis has not yet been completely understood. Few publications have tried to establish a link between the general clinical presentation of the illness and its neurological manifestations., Objective: To evaluated the portal blood flow in patients with schistosomal myelitis and controls., Method: Forty-three individuals were evaluated using portal Doppler ultrasound. Group I consisted of 13 patients with the spinal form of schistosomiasis. Group II included 10 patients with intestinal and hepatointestinal forms of schistosomiasis, but no neurological symptoms; while group III involved 20 healthy controls., Results: Portal venous speed and portal venous flow were significantly elevated in group I (p<0.001) compared with the others., Conclusion: Doppler ultrasound demonstrated a situation of high flow within the portal venous system of patients with schistosomal myelitis.
- Published
- 2010
- Full Text
- View/download PDF
45. Diagnostic methods for extra-temporal neocortical focal epilepsies: present and future.
- Author
-
Leite RA, Otaduy MC, Silva GE, Ferreira ML, and Aragão Mde F
- Subjects
- Diagnostic Imaging methods, Diagnostic Imaging trends, Electroencephalography, Epilepsy physiopathology, Forecasting, Humans, Neocortex chemistry, Epilepsy diagnosis, Functional Laterality physiology, Neocortex physiopathology
- Abstract
The progress of epilepsies diagnosis has been great, but, amongst the diagnostic detailing that demand research, one of the most important is the essential lateralization and localization of epileptogenic zone, considered as the cerebral cortex region, that removed, will result in a free state of seizures. The present study aims to analyze the possible uses of proton spectroscopy for clinical and pre-surgical evaluation of focal extratemporal epilepsies, since this group presents the highest difficulty degree for lateralizing and locating epileptogenic zones. In almost all cases, a non invasive diagnosis can be performed using routine electroencephalography, video-electroencephalography - considered as gold standard, and magnetic resonance imaging. However, when the results of these exams are contradictory, some patients need invasive techniques, as the intra-cranial video-EEG, using deep electrodes, sub-dural strip and grid, that are associated with increased diagnostic cost and risk of complications, as cerebral hemorrhages and intra-cranial infections. Proton spectroscopy appears as a possibility, given its capacity to evaluate cerebral metabolism, by N-acetyl-aspartate (NAA), creatine (Cre) and choline (Cho) concentrations, amongst other metabolites. This non invasive method may provide time reduction of this evaluation and reliable level improvement for this topographical diagnosis.
- Published
- 2010
- Full Text
- View/download PDF
46. Alicata disease: neuroinfestation by Angiostrongylus cantonensis in Recife, Pernambuco, Brazil.
- Author
-
Lima AR, Mesquita SD, Santos SS, Aquino ER, Rosa Lda R, Duarte FS, Teixeira AO, Costa ZR, and Ferreira ML
- Subjects
- Adult, Angiostrongylus cantonensis, Animals, Antiparasitic Agents therapeutic use, Central Nervous System Helminthiasis drug therapy, Central Nervous System Helminthiasis parasitology, Female, Humans, Ivermectin therapeutic use, Meningoencephalitis drug therapy, Meningoencephalitis parasitology, Methylprednisolone therapeutic use, Strongylida Infections drug therapy, Central Nervous System Helminthiasis diagnosis, Meningoencephalitis diagnosis, Strongylida Infections diagnosis
- Published
- 2009
- Full Text
- View/download PDF
47. Splenic marginal zone lymphoma--a clinicopathological study in a series of 16 patients.
- Author
-
Raya JM, Ruano JA, Bosch JM, Golvano E, Molero T, Lemes A, Cuesta J, Brito ML, and Hernández-Nieto L
- Subjects
- Adult, Aged, Bone Marrow pathology, Bone Marrow Examination, CD5 Antigens, Female, Humans, Immunophenotyping, Lymphoma, B-Cell, Marginal Zone classification, Lymphoma, B-Cell, Marginal Zone diagnosis, Male, Middle Aged, Neoplasm Invasiveness, Retrospective Studies, Spleen pathology, Lymphoma, B-Cell, Marginal Zone pathology
- Abstract
Splenic marginal zone lymphoma (SMZL), characterized in the WHO classification of lymphoid tumors, is a rare disorder comprising less than 1% of lymphoid neoplasms; only a few series concerning this entity have been published. Although this type of lymphoma is well defined histologically, its histogenesis remains obscure. Moreover, specific biological markers are still lacking and immunophenotype profile is not specific. These and other reasons, such as the existence of cytogenetic subtypes, have led to some authors to suspect that SMZL constitutes a heterogeneous entity. We have analyzed a series of sixteen SMZL cases from four hospitals in our community, from a clinical, biological and pathological point of view. When compared with those reported in the literature, our findings show three main differences: our patients less frequently showed an intrasinusoidal bone marrow infiltration pattern; the presence of a serum monoclonal component was rarely seen; and CD5-positive SMZL cases appear to be more common than previously thought.
- Published
- 2008
- Full Text
- View/download PDF
48. Pediatric multiple sclerosis: analysis of clinical and epidemiological aspects according to National MS Society Consensus 2007.
- Author
-
Ferreira ML, Machado MI, Dantas MJ, Moreira AJ, and Souza AM
- Subjects
- Adolescent, Age of Onset, Brazil epidemiology, Child, Child, Preschool, Cohort Studies, Disability Evaluation, Female, Humans, Infant, Male, Multiple Sclerosis diagnosis, Prospective Studies, Recurrence, Multiple Sclerosis complications, Multiple Sclerosis epidemiology
- Abstract
Objective: To describe the epidemiological and clinical characteristics of child/adolescence multiple sclerosis (MS)., Method: According to a descriptive, cohort study, with comparison of groups, data of 31 cases of child/adolescent MS, diagnosed at State Reference Center for Demyelinating Diseases-Hospital da Restauração, Recife, Pernambuco, Brazil, from 1987 to July 2007, were analyzed. The variables were: sex, initial symptoms, time for diagnosis, time of disease onset (early childhood, later childhood and adolescence), time of follow-up, number of relapses, relapses index and disability. Using SPSS software, version 13.0, t Student and Mann-Whitney tests were performed, with significance level of 0.05., Results: There were 3 (9.7%) cases of early childhood MS, 9 (29%), of late childhood MS, and 19 (61.3%), of adolescence MS. The general sex rate female: male was 1.8:1, varying according to age of onset. The predominant deficits were motor (12; 38.7%) and brainstem/cerebellum (7; 22.5%) especially on subsequent relapses of relapsing/remitting form. Time for diagnosis and average relapses index were higher in early childhood than in adolescence class (p=0.049 and p=0.028, respectively). Disability was higher for primary and secondary MS, as well as for early childhood., Conclusion: Early childhood MS presents proper and different characteristics from adults, consisting in a difficult diagnosis that demands aid of expert neurologist on MS.
- Published
- 2008
- Full Text
- View/download PDF
49. Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.
- Author
-
Machado P, Raya JM, Martín T, Morabito L, Brito ML, and Rodríguez-Martín JM
- Subjects
- Adult, Antibodies, Monoclonal, Murine-Derived, Autoantibodies blood, Autoantibodies immunology, Blood Coagulation Factor Inhibitors blood, Blood Coagulation Factor Inhibitors immunology, Factor VIII antagonists & inhibitors, Factor VIII immunology, Female, Hemophilia A blood, Hemophilia A immunology, Humans, Male, Middle Aged, Rituximab, Antibodies, Monoclonal administration & dosage, Hemophilia A drug therapy, Immunologic Factors administration & dosage
- Abstract
Acquired autoantibodies against coagulation factors (acquired haemophilia) frequently constitute a life-threatening bleeding situation requiring a prompt therapeutic intervention, including control of bleeding and secondarily an attempt of eradication of the inhibitor by prolonged immunosuppressive therapy. The combination of oral corticosteroids and cyplophosphamide seems to be effective to eradicate the autoantibody, but some patients may be resistant. Another therapeutic approach, recently described, observes treatment with the chimeric anti-CD20 monoclonal antibody rituximab. We report two consecutively treated patients whose acquired FVIII inhibitors did not respond to standard immunosuppressive regimens, and only when rituximab was added to therapy, complete response and prolonged remission were obtained.
- Published
- 2008
- Full Text
- View/download PDF
50. [Electromyografic patterns predictive of motor evolution in neuroschistosomiasis].
- Author
-
Correia Cda C, Ataíde Júnior L, Lins OG, and Ferreira ML
- Subjects
- Humans, Peripheral Nervous System Diseases diagnosis, Predictive Value of Tests, Electromyography, Neuroschistosomiasis complications, Peripheral Nervous System Diseases parasitology
- Abstract
Neuroschistosomiasis in myeloradicular pattern is frequently observed in patients from Northeast of Brazil. Despite of this, the evolution of neurologic and electromyographic patterns is not well studied in this group of patients. The aims of this study were to describe and compare the clinic and electromyographic abnormalities of patients with neuroschistosomiasis and radicular involvement. We analyzed 21 electromyographic exams of the lower limbs carried out in the initial presentation of the disease. Electromyographic pattern of 95.2% of patients was compatible to axonal lumbosacral multirradiculopathy, with variable denervation extension, but predominantly from levels L2 to S2. There was variable degree of deficit in the lower limbs, and the follow-up of motor disturbances was better more frequently when the roots were involved in smaller number. Electromyography should permit to know the motor prognosis of patients with myeloradiculitis due schistosomiasis.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.